These results suggested that treatment with 17-βE loaded CREKA-peptide modified nanoemulsion or with the blank nanoemulsion alone can thus help reduce the atherosclerotic plaque burden by down-regulating the expression of genes that promote atherosclerosis in the ApoE-/- mice. Here, APOE is linked to atherosclerosis.